BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29367744)

  • 1. Overexpression of parkin protects retinal ganglion cells in experimental glaucoma.
    Dai Y; Hu X; Sun X
    Cell Death Dis; 2018 Jan; 9(2):88. PubMed ID: 29367744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirt6 protects retinal ganglion cells and optic nerve from degeneration during aging and glaucoma.
    Xia F; Shi S; Palacios E; Liu W; Buscho SE; Li J; Huang S; Vizzeri G; Dong XC; Motamedi M; Zhang W; Liu H
    Mol Ther; 2024 Jun; 32(6):1760-1778. PubMed ID: 38659223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation.
    Yu N; Wu X; Zhang C; Qin Q; Gu Y; Ke W; Liu X; Zhang Q; Liu Z; Chen M; Wang K
    Biomed Pharmacother; 2024 Jun; 175():116711. PubMed ID: 38735082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs/GABA
    Ishikawa M; Takaseki S; Yoshitomi T; Covey DF; Zorumski CF; Izumi Y
    Autophagy; 2021 Mar; 17(3):743-760. PubMed ID: 32070183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors.
    Almasieh M; Zhou Y; Kelly ME; Casanova C; Di Polo A
    Cell Death Dis; 2010; 1(2):e27. PubMed ID: 21364635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma.
    Yang F; Wang D; Wu L; Li Y
    Drug Des Devel Ther; 2015; 9():6095-107. PubMed ID: 26604697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Müller cells under hydrostatic pressure modulate retinal cell survival via TRPV1/PLCγ1 complex-mediated calcium influx in experimental glaucoma.
    Hu H; Nie D; Fang M; He W; Zhang J; Liu X; Zhang G
    FEBS J; 2024 Jun; 291(12):2703-2714. PubMed ID: 38390745
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Yadav KS; Bisen AC; Ishteyaque S; Sharma I; Verma S; Sanap SN; Verma S; Washimkar KR; Kumar A; Tripathi V; Bhatta RS; Mugale MN
    J Ocul Pharmacol Ther; 2024 Jun; 40(5):309-324. PubMed ID: 38603587
    [No Abstract]   [Full Text] [Related]  

  • 9. The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model.
    Anders F; Liu A; Mann C; Teister J; Lauzi J; Thanos S; Grus FH; Pfeiffer N; Prokosch V
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration.
    Al Hussein Al Awamlh S; Wareham LK; Risner ML; Calkins DJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and noninvasive imaging of retinal ganglion cells in live mouse models of glaucoma.
    Tosi J; Wang NK; Zhao J; Chou CL; Kasanuki JM; Tsang SH; Nagasaki T
    Mol Imaging Biol; 2010 Aug; 12(4):386-93. PubMed ID: 19937134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulated Necrosis in Glaucoma: Focus on Ferroptosis and Pyroptosis.
    Chen D; Miao S; Chen X; Wang Z; Lin P; Zhang N; Yang N
    Mol Neurobiol; 2024 May; 61(5):2542-2555. PubMed ID: 37910286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alpha.
    Agarwal R; Agarwal P
    Indian J Ophthalmol; 2012 Jul; 60(4):255-61. PubMed ID: 22824592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis in Glaucoma: A Promising Avenue for Therapy.
    Zhu J; Chen H; Wu J; Li S; Lin W; Wang N; Bai L
    Adv Biol (Weinh); 2024 May; 8(5):e2300530. PubMed ID: 38411382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling enigmatic essence of Sphingolipids: A promising avenue for glaucoma treatment.
    Iezhitsa I; Agarwal R; Agarwal P
    Vision Res; 2024 Aug; 221():108434. PubMed ID: 38805893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma.
    Pang Y; Wang C; Yu L
    Med Hypothesis Discov Innov Ophthalmol; 2015; 4(3):120-6. PubMed ID: 27350953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging, Cellular Senescence, and Glaucoma.
    Zhang Y; Huang S; Xie B; Zhong Y
    Aging Dis; 2024 Apr; 15(2):546-564. PubMed ID: 37725658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin B
    Almeida J; Costa TR; Vivas M; Monteiro C; Vaz FT; Ferreira Q; Prieto I; Pinto LA; Ferreira JT
    J Ocul Pharmacol Ther; 2024 Mar; 40(2):111-116. PubMed ID: 38150537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Epigenetic Modifications as Potential Biomarkers and Therapeutic Targets in Glaucoma.
    Tonti E; Dell'Omo R; Filippelli M; Spadea L; Salati C; Gagliano C; Musa M; Zeppieri M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced mitochondrial biogenesis promotes neuroprotection in human pluripotent stem cell derived retinal ganglion cells.
    Surma M; Anbarasu K; Dutta S; Olivera Perez LJ; Huang KC; Meyer JS; Das A
    Commun Biol; 2023 Feb; 6(1):218. PubMed ID: 36828933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.